share_log

Barclays Maintains Overweight on Exscientia, Lowers Price Target to $10

Benzinga ·  Oct 17, 2023 08:17

Barclays analyst Peter Lawson maintains Exscientia (NASDAQ:EXAI) with a Overweight and lowers the price target from $12 to $10.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment